The Anatomy of Fear LEAVE A REPLY Cancel reply TAGSNational Center for SimulationOrange County Previous articleOrange County Budget: Admin Services drop slightlyNext article10 Race Prep Tips You Need to Know Denise Connell RELATED ARTICLESMORE FROM AUTHOR Florida Simulation Summit to be Held September 7th: Keynote Speaker from Ford Motor Company’s Digital Innovation GroupFrom the Orange County Public Information OfficeOrange County Mayor Teresa Jacobs and the National Center for Simulation will host the Florida Simulation Summit on September 7, 2017, from 9 a.m. to 5 p.m. at the Orange County Convention Center, West Concourse, located at 9800 International Drive.Now in its third year, the Florida Simulation Summit’s theme is “Experience the New Reality.” The event will showcase the transformation and advancement of transportation, medical, architecture, and engineering industries through the use of virtual and augmented reality. The Summit’s goal is to highlight the state’s multi-billion-dollar modeling, simulation, and training (MS&T) industry and will feature various simulation experts.The keynote speaker is Elizabeth Baron at Ford Motor Co.’s Virtual Reality and Advanced Technical Specialist. Baron manages Ford’s Virtual Reality Center in Product Development that provides immersive virtual reality systems used for design and product development. As part of the Digital Innovation Group at Ford, Baron’s goal is to address the unique challenges of automotive design and engineering in the digital age. The Summit speakers also include experts from Tesla, Luminar Technologies, Inc. (autonomous vehicles), the I-4 Ultimate Improvement Project, Orlando International Airport, PCL Construction, Nemours Children’s Hospital and the University Florida.“From scientific discovery to the creation of high-value jobs, the MS&T sector will provide unlimited opportunities for generations to come,” Mayor Jacobs said. “We are inspired by this sector’s innovation and all of the emerging simulation technologies and applications highlighted at the Florida Simulation Summit. We’re creating a vision for the future and an environment that fosters collaboration, productivity, profitability and jobs in Orange County.”To protect this valued economic cluster, Orange County responded to looming threats posed by potential defense spending cuts and base closures by forming the MS&T Blue Ribbon Commission in 2013. The Commission is a coalition of community leaders and industry stakeholders that advocates for this high-value and high-wage economic sector in Florida.The Commission continues to educate key audiences regarding the high level of synergy between MS&T and other key sectors of our economy, including medical, gaming, education, aviation, aerospace, animation, theme park, emergency management and public safety.“Mayor Jacobs’ Blue Ribbon Commission on MS&T created the Florida Simulation Summit to help demonstrate how the MS&T industry is vital, not only to our local defense industry but also to many industries throughout our community,” said president and CEO of the National Center for Simulation, retired Air Force Lt. Gen. Thomas L. Baptiste. “Virtual and augmented reality technology can help grow our diverse local industry sectors in new and exciting directions.”The event cost is $25 in advance or $50 at the door. Parking is free. For registration and directions, visit the National Center for Simulation’s website at www.simulationinformation.com. For more information, contact 407-836-9673 or email Eric Ushkowitz at [email protected] the National Center for Simulation: National Center for Simulation (NCS) is a non-profit trade association whose vision is to lead the growth of modeling, simulation, and training. NCS is committed to promoting modeling and simulation technology expansion, supporting education and workforce development, and providing business development support to its members. For more information, visit www.simulationinformation.com. Please enter your name here Share on Facebook Tweet on Twitter Please enter your comment! Support conservation and fish with NEW Florida specialty license plate Free webinar for job seekers on best interview answers, hosted by Goodwill June 11 You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment.
Home Indiana Agriculture News Task Force Wants Antibiotic Resistance Solutions Task Force Wants Antibiotic Resistance Solutions By Andy Eubank – Nov 12, 2015 SHARE SHARE A report on the growing problem of antibiotic resistance in animal agriculture spotlights the need to make finding solutions a top priority. The 14-member Task Force on Antibiotic Resistance in Production Agriculture is composed of agricultural educators, industry leaders, and animal health specialists. The report recommends creating a centralized organization to coordinate public and private efforts to curb resistance. The Center for Disease Control said antibiotic-resistant bacteria cause at least two million human illnesses and 23,000 deaths a year. The financial cost is near $20 billion a year in direct health care costs. The Task Force said resistance not only threatens human health but animal and environmental health too.Source: NAFB News Service Facebook Twitter Previous articleMonsanto Net Income Forecast LowerNext articleUSB Transitions Focus to Promoting U.S. Quality Andy Eubank Facebook Twitter
Moderna said it has selected the 100-microgram dose of the vaccine for the late-stage study. At that dose level, the company is on track to deliver about 500 million doses per year, and possibly up to 1 billion doses per year, starting in 2021 from the company’s internal US manufacturing site and strategic collaboration with Swiss drugmaker Lonza.The company said it chose the 100-microgram dose to maximize the immune response and minimize adverse reactions.Moderna said is has completed manufacturing of enough vaccine to start the phase 3 trial.In the midstage study, the company said it has enrolled 300 healthy adults, who have each been dosed with at least one shot, as well as the first 50 older adults, aged 18 to 54.Testing the vaccine in older adults with be critical because this group is at higher risk for the most severe effects of the virus, and older adults typically have less efficient immune function. The midstage study is testing the safety and preliminary effectiveness of two doses of the vaccine given 28 days apart.Study participants will be followed for a year.Topics : Moderna Inc on Thursday confirmed it plans to start a trial of 30,000 volunteers of its much-anticipated coronavirus vaccine in July as the company enters the final stage of testing.The Cambridge, Massachusetts-based biotech said the primary goal of the study would be to prevent symptomatic COVID-19, the disease caused by the novel coronavirus. The key secondary goal would be prevention of severe disease, as defined by keeping people out of the hospital.The company’s shares jumped 6 percent in premarket trading.